Edition:
India

Progenics Pharmaceuticals Inc (PGNX.OQ)

PGNX.OQ on NASDAQ Stock Exchange Global Select Market

6.27USD
19 Jan 2018
Change (% chg)

$0.17 (+2.79%)
Prev Close
$6.10
Open
$6.10
Day's High
$6.30
Day's Low
$6.08
Volume
276,203
Avg. Vol
249,147
52-wk High
$11.71
52-wk Low
$4.61

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 2.77 -0.237
Mar '17 2.35 -0.233
FY 2016 Dec '16 4.65 -0.103
Sep '16 53.85 0.516
Jun '16 8.48 -0.081
Mar '16 2.45 -0.181
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 1 4.70 4.70 4.70 --
Quarter Ending Jun-18 1 9.30 9.30 9.30 --
Year Ending Dec-18 4 41.52 48.90 32.10 103.33
Earnings (per share)
Quarter Ending Mar-18 1 -0.19 -0.19 -0.19 --
Quarter Ending Jun-18 1 -0.15 -0.15 -0.15 --
Year Ending Dec-18 4 -0.62 -0.47 -0.73 0.17
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % 700.24 106.70 -3.92
EPS (TTM) % 127.46 -- -13.05
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Progenics Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 18.99 14.89 82 --
13 Week 8.75 3.46 68 --
26 Week -13.46 -20.04 36 --
52 Week 3.82 -12.00 53 --
YTD -15.16 -25.50 30 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 86.98%
# of Holders: 205
Total Shares Held: 61,119,519
3 Mo. Net Change: 51,888
# New Positions: 4
# Closed Positions: 2
# Increased Positions: 12
# Reduced Positions: 8
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.